Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
984315 | Research Policy | 2007 | 24 Pages |
Abstract
This paper argues that despite being widely promoted by academics and consultants, the empirical evidence does not support the existence of a biotech revolution. Nor does the data support the widely held expectations that biotechnology is having a revolutionary impact on healthcare or economic development. The revolutionary model is therefore a misleading basis for policy making as it over-estimates the speed and extent of any changes in productivity or the quality of therapeutics. Instead, the evidence suggests biotechnology is following a well-established incremental pattern of technological change and ‘creative accumulation’ that builds upon, rather than disrupts, previous drug development heuristics.
Related Topics
Social Sciences and Humanities
Business, Management and Accounting
Business and International Management
Authors
Michael M. Hopkins, Paul A. Martin, Paul Nightingale, Alison Kraft, Surya Mahdi,